3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Peripheral Nervous System Diseases
3
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Breast Neoplasms
2
Wilms Tumor
1
Vaso-Occlusive Crises
1
Sarcoma
1
Prostatic Neoplasms
1
Pain
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Esophagitis
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Anemia, Sickle Cell
1
Interventions
Oxaliplatin
4
Leucovorin
4
Irinotecan
4
Fluorouracil
4
Capecitabine
3
Bevacizumab
3
cobimetinib
2
Tomography, X-Ray Computed
2
Surveys and Questionnaires
2
Standard of Care
2
Specimen Handling
2
Panitumumab
2
Magnetic Resonance Spectroscopy
2
Ketamine
2
Hydroxychloroquine
2
Cyclophosphamide
2
Cisplatin
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
sodium thiosulfate
1
rucaparib
1
romiplostim
1
rilotumumab
1
regorafenib
1
pralsetinib
1
ponatinib
1
pembrolizumab
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Neoplasms
×
Glutamine
×
Clear all
No trials found.